22nd week of 2016 patent applcation highlights part 20 |
Patent application number | Title | Published |
20160152625 | Nalmefene Salts as Medicaments for Reducing Alcohol Consumption or for Preventing Excessive Alcohol Consumption | 2016-06-02 |
20160152626 | PYRAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF | 2016-06-02 |
20160152627 | TRICYCLIC PYRIDO-CARBOXAMIDE DERIVATIVES AS ROCK INHIBITORS | 2016-06-02 |
20160152628 | TRICYCLIC PYRIDO-CARBOXAMIDE DERIVATIVES AS ROCK INHIBITORS | 2016-06-02 |
20160152629 | UV-CURING-COMPATIBLE PHOTOCHROMIC FUSED NAPHTHOPYRANS | 2016-06-02 |
20160152630 | DIANHYDRIDES, POLYIMIDES, METHODS OF MAKING EACH, AND METHODS OF USE | 2016-06-02 |
20160152631 | SYNTHETIC PROCESS FOR PREPARATION OF MACROCYCLIC C1-KETO ANALOGS OF HALICHONDRIN B AND INTERMEDIATES USEFUL THEREIN | 2016-06-02 |
20160152632 | PHARMACEUTICAL COMPOUNDS | 2016-06-02 |
20160152633 | NOVEL ORGANIC COMPOUND | 2016-06-02 |
20160152634 | THIENO- AND FURO - PYRIMIDINES AND PYRIDINES, USEFUL AS POTASSIUM CHANNEL INHIBITORS | 2016-06-02 |
20160152635 | THIENOPYRIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS | 2016-06-02 |
20160152636 | COMPOUND HAVING PERFLUOROALKYL TERMINAL GROUP AND CF2O BONDING GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | 2016-06-02 |
20160152637 | 2-Amino-6-Methyl-4,4a,5,6-Tetrahydropyrano[3,4-d][1,3]Thiazin-8a(8H)-yl-1,- 3-Thiazol-4-yl Amides | 2016-06-02 |
20160152638 | MULTISTIMULI-RESPONSIVE WHITE LUMINESCENT MATERIALS INCLUDING METAL ELEMENTS | 2016-06-02 |
20160152639 | POLYMERIC COMPOUND AND ELECTRONIC ELEMENT | 2016-06-02 |
20160152640 | HEXACOORDINATE SILICON-CONTAINING PRECURSORS FOR ALD/CVD SILICON-CONTAINING FILM APPLICATIONS | 2016-06-02 |
20160152641 | BONDING METHOD, BONDABILITY IMPROVING AGENT, SURFACE MODIFICATION METHOD, SURFACE MODIFYING AGENT, AND NOVEL COMPOUND | 2016-06-02 |
20160152642 | FLOURINE-CONTAINING COMPOUND, SUBSTRATE FOR PATTERNING, PHOTODEGRADABLE COUPLING AGENT, PATTERNING METHOD, AND COMPOUND | 2016-06-02 |
20160152643 | PHOSPHORUS-CONTAINING COMPOUND, AND CURABLE EPOXY RESIN COMPOSITION CONTAINING SAME | 2016-06-02 |
20160152644 | METHODS FOR THE PREPARATION OF HIV ATTACHMENT INHIBITOR PIPERAZINE PRODRUG COMPOUND | 2016-06-02 |
20160152645 | TRANSITION METAL CARBENE COMPLEX AND METHOD OF PRODUCING THE SAME | 2016-06-02 |
20160152646 | PLATINUM COMPOUNDS HAVING A HETEROCYCLE LIGAND, NANOPARTICLES, AND USES THEREOF | 2016-06-02 |
20160152647 | NOVEL NICKEL-BASED COMPLEX AND USE THEREOF IN A METHOD FOR THE OLIGOMERISATION OF OLEFINS | 2016-06-02 |
20160152648 | METAL OXIDE-ORGANIC HYBRID MATERIALS FOR HETEROGENEOUS CATALYSIS AND METHODS OF MAKING AND USING THEREOF | 2016-06-02 |
20160152649 | METAL AMIDES OF CYCLIC AMINES | 2016-06-02 |
20160152650 | THERMALLY STABLE VOLATILE PRECURSORS | 2016-06-02 |
20160152651 | Double Metal Cyanide Catalyst and Epoxide/Carbon Dioxide Copolymer Prepared Using the Same | 2016-06-02 |
20160152652 | METHOD OF MANUFACTURING D-GALACTOSE FOR USE OF THE PRODUCTION OF D-TAGATOSE FROM WHEY PERMEATE OR DRIED WHEY PERMEATE | 2016-06-02 |
20160152653 | NOVEL AMINOGLYCOSIDE ANTIBIOTICS | 2016-06-02 |
20160152654 | TRIAZOLE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | 2016-06-02 |
20160152655 | 2', 3'- DIDEOXY-5-FLUOROURIDINE DERIVATIVES, A PROCESS FOR THE MANUFACTURE THEREOF AND APPLICATION THEREOF | 2016-06-02 |
20160152656 | Methods of Using Phosphoramidation Reaction for Conjugation-Labeling Nucleic Acids | 2016-06-02 |
20160152657 | Steroids as Agonists for FXR | 2016-06-02 |
20160152658 | NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF | 2016-06-02 |
20160152659 | NOVEL SOLANIDINE-DERIVED COMPOUNDS | 2016-06-02 |
20160152660 | AN ARRANGEMENT FOR A COLUMN, A METHOD FOR SUBSTITUTING A TUBULAR HOUSING IN SUCH AN ARRANGEMENT FOR A COLUMN AND A METHOD FOR CONDUCTING PEPTIDE AND/OR OLIGONUCLEOTIDE SYNTHESIS IN A COLUMN | 2016-06-02 |
20160152661 | PROCESS FOR ISOLATION AND PURIFICATION OF A TARGET PROTEIN FREE OF PRION PROTEIN (PRPSC) | 2016-06-02 |
20160152662 | LIGAND FUNCTIONAL SUBSTRATES | 2016-06-02 |
20160152663 | USE OF RUTHENIUM COMPLEXES FOR FORMATION AND/OR HYDROGENATION OF AMIDES AND RELATED CARBOXYLIC ACID DERIVATIVES | 2016-06-02 |
20160152664 | NOVEL a4B7 PEPTIDE MONOMER AND DIMER ANTAGONISTS | 2016-06-02 |
20160152665 | Compositions and Methods of Treatment of Cancers | 2016-06-02 |
20160152666 | RECOMBINANT VIRAL VECTORS | 2016-06-02 |
20160152667 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS | 2016-06-02 |
20160152668 | Mutated Immunoglobulin-Binding Protein | 2016-06-02 |
20160152669 | NOVEL POLYPEPTIDE, AND USE THEREOF | 2016-06-02 |
20160152670 | SELECTIVE DELIVERY MOLECULES AND METHODS OF USE | 2016-06-02 |
20160152671 | CHLOROTOXIN POLYPEPTIDES AND CONJUGATES AND USES THEREOF | 2016-06-02 |
20160152672 | Reagents and Methods for Treating Dental Disease | 2016-06-02 |
20160152673 | Dopaminergic Neuronal Survival-Promoting Factors and Uses Thereof | 2016-06-02 |
20160152674 | TDF-RELATED COMPOUNDS AND ANALOGS THEREOF | 2016-06-02 |
20160152675 | COMPOSITIONS AND METHODS RELATED TO TAUOPATHY | 2016-06-02 |
20160152676 | HELIX-GRAFTED PROTEINS AS INHIBITORS OF DISEASE-RELEVANT PROTEIN-PROTEIN INTERACTIONS | 2016-06-02 |
20160152677 | SINGLE DOMAIN TDF-RELATED COMPOUNDS AND ANALOGS THEREOF | 2016-06-02 |
20160152678 | MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF ONCOLOGY-RELATED PROTEINS AND PEPTIDES | 2016-06-02 |
20160152679 | RELAXIN-LIKE COMPOUNDS AND USES THEREOF | 2016-06-02 |
20160152680 | TARGETED THERAPEUTIC PROTEINS | 2016-06-02 |
20160152681 | ANTI-HUMAN PAPILLOMAVIRUS 16 E6 T CELL RECEPTORS | 2016-06-02 |
20160152682 | ILT3 Polypeptides and Uses Thereof | 2016-06-02 |
20160152683 | NOVEL ACTIVIN RECEPTOR AND USES THEREOF | 2016-06-02 |
20160152684 | IMMUNOGLOBULIN FC CONJUGATE WHICH MAINTAINS BINDING AFFINITY OF IMMUNOGLOBULIN FC FRAGMENT TO FCRN | 2016-06-02 |
20160152685 | SMALL MOLECULE-DEPENDENT INTEINS AND USES THEREOF | 2016-06-02 |
20160152686 | FIBRONECTIN BASED SCAFFOLD DOMAINS LINKED TO SERUM ALBUMIN OR MOIETY BINDING THERETO | 2016-06-02 |
20160152687 | ALBUMIN FUSION PROTEINS | 2016-06-02 |
20160152688 | TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS THAT BIND EGFR | 2016-06-02 |
20160152689 | COMPOSITIONS AND METHODS FOR INHIBITING THROMBOGENESIS | 2016-06-02 |
20160152690 | PROCESS FOR INCREASED YIELD OF IMMUNOGLOBULIN FROM HUMAN PLASMA | 2016-06-02 |
20160152691 | RNA-CODED ANTIBODY | 2016-06-02 |
20160152692 | INFLUENZA VIRUS-NEUTRALIZING ANTIBODY AND SCREENING METHOD THEREFOR | 2016-06-02 |
20160152693 | AMINO ACID SEQUENCES DIRECTED AGAINST ENVELOPE PROTEINS OF A VIRUS AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF VIRAL DISEASES | 2016-06-02 |
20160152694 | ANTIBODIES AGAINST CLOSTRIDIUM DIFFICILE TOXINS AND USES THEREOF | 2016-06-02 |
20160152695 | METHODS AND DEVICE TO NEUTRALIZE SOLUBLE TOXIC AGENTS IN THE BRAIN | 2016-06-02 |
20160152696 | ANTIBODIES TO 2-GLYCOPROTEIN I AND THERAPEUTIC USES THEREOF | 2016-06-02 |
20160152697 | METHODS, COMPOSITIONS AND APPARATUSES FOR FACILITATING REGENERATION | 2016-06-02 |
20160152698 | ANTI-NGF ANTIBODIES AND METHODS USING SAME | 2016-06-02 |
20160152699 | PAN-ELR+ CXC CHEMOKINE ANTIBODIES | 2016-06-02 |
20160152700 | Antigen Binding Proteins Capable of Binding Thymic Stromal Lymphopoietin | 2016-06-02 |
20160152701 | INDUCIBLE EXPRESSION SYSTEM | 2016-06-02 |
20160152702 | METHODS FOR CONTROLLING THE GALACTOSYLATION PROFILE OF RECOMBINANTLY-EXPRESSED PROTEINS | 2016-06-02 |
20160152703 | ANTI-CDH3 HUMANIZED ANTIBODY, DRUG CONJUGATE THEREOF, AND USE THEREOF | 2016-06-02 |
20160152704 | CADHERIN 15 AGONISTS | 2016-06-02 |
20160152705 | USE OF A CD6 BINDING PARTNER AND METHOD BASED THEREON | 2016-06-02 |
20160152706 | RNA-CODED ANTIBODY | 2016-06-02 |
20160152707 | CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS | 2016-06-02 |
20160152708 | METHOD OF INHIBITING BINDING OR ACTIVITY OF MIF BY ADMINISTERING A MIF ANTAGONIST | 2016-06-02 |
20160152709 | COMPOSITIONS AND METHODS FOR TREATMENT OF STROKE | 2016-06-02 |
20160152710 | MILK FAT GLOBULE EPIDERMAL GROWTH FACTOR 8 REGULATES FATTY ACID UPTAKE | 2016-06-02 |
20160152711 | DESIGN AND DEVELOPMENT OF MASKED THERAPEUTIC ANTIBODIES TO LIMIT OFF-TARGET EFFECTS: APPLICATION TO ANTI-EGFR ANTIBODIES | 2016-06-02 |
20160152712 | COMPOSITIONS AND METHODS FOR TREATING CANCER RESISTANT TO A TYROSINE KINASE INHIBITOR (TKI) | 2016-06-02 |
20160152713 | ANTIBODIES TO CD40 | 2016-06-02 |
20160152714 | SUBTYPES OF HUMANIZED ANTIBODY AGAINST INTERLEUKIN-6 RECEPTOR | 2016-06-02 |
20160152715 | COMBINATION THERAPY FOR CANCER | 2016-06-02 |
20160152716 | METHODS FOR IDENTIFYING IMMUNOBINDERS OF CELL-SURFACE ANTIGENS | 2016-06-02 |
20160152717 | METHODS FOR TREATING DRY EYE DISEASE BY ADMINISTERING AN IL-6R ANTAGONIST | 2016-06-02 |
20160152718 | Methods for treating eosinophilic esophagitis by administering an IL-4R inhibitor | 2016-06-02 |
20160152719 | COMPOSITIONS AND METHODS RELATED TO STRUCTURES THAT CROSS THE BLOOD BRAIN BARRIER | 2016-06-02 |
20160152720 | COMBINATION THERAPY COMPRISING OX40 BINDING AGONISTS AND TIGIT INHIBITORS | 2016-06-02 |
20160152721 | SILENT Fc VARIANTS OF ANTI-CD40 ANTIBODIES | 2016-06-02 |
20160152722 | COMBINATIONS OF ANTI-4-1BB ANTIBODIES AND ADCC-INDUCING ANTIBODIES FOR THE TREATMENT OF CANCER | 2016-06-02 |
20160152723 | ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR CD19 | 2016-06-02 |
20160152724 | A NEW FUSION PROTEIN TO TARGET AND TREAT ACUTE MYLOID LEUKEMIA CELLS | 2016-06-02 |